Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 4.66 +0.32 (+7.37%) Jul 21
At Loss
P/B:
2.58
Market Cap:
€ 487.03M ($ 555.47M)
Enterprise V:
€ 282.06M ($ 321.69M)
Volume:
0
Avg Vol (2M):
1.87K
Trade In:

Relmada Therapeutics Inc Valuation Measures